SRS Capital Advisors, Inc. - AMPIO PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
SRS Capital Advisors, Inc. ownership history of AMPIO PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$6,000
-94.3%
98,472
-84.3%
0.00%
-93.8%
Q2 2022$106,000
-64.2%
629,1720.0%0.02%
-59.0%
Q1 2022$296,000
-17.5%
629,1720.0%0.04%
-15.2%
Q4 2021$359,000
-65.6%
629,1720.0%0.05%
-67.8%
Q3 2021$1,044,000
-0.7%
629,1720.0%0.14%0.0%
Q2 2021$1,051,000
+7.4%
629,172
+2.2%
0.14%
-1.4%
Q4 2020$979,000
+66.2%
615,6590.0%0.14%
+46.5%
Q3 2020$589,000
+50.3%
615,6590.0%0.10%
+41.4%
Q2 2020$392,000
-46.6%
615,659
-65.2%
0.07%
-58.6%
Q1 2020$734,0001,768,1590.17%
Other shareholders
AMPIO PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Cypress Capital Management LLC (WY) 234,225$132,0000.18%
Noven Financial Group, Inc. 123,772$70,0000.04%
Harvest Investment Services, LLC 109,443$60,0000.04%
GSA CAPITAL PARTNERS LLP 559,489$314,0000.03%
COURIER CAPITAL LLC 354,973$199,0000.03%
Valeo Financial Advisors, LLC 330,000$185,0000.02%
Transform Wealth, LLC 205,481$115,0000.02%
WEDBUSH SECURITIES INC 326,793$184,0000.02%
STEEL GROVE CAPITAL ADVISORS, LLC 55,500$31,0000.02%
MONTAG A & ASSOCIATES INC 230,000$129,0000.01%
View complete list of AMPIO PHARMACEUTICALS INC shareholders